PXL Platinum 330
Corneal Cross Linking Corneal Cross Linking (CXL) is a treatment with the aim of strengthening the corneal stromal tissue through the formation of new chemical bonds between stromal fibres.
CXL is the only effective non-invasive treatment to stop progressive keratoconus as well as related ectatic disorders (such as PMD and iatrogenic ectasia) and has a regularization effect on corneal topography. In addition to its role in treating ectatic corneal diseases, CXL has an established place in the management of infectious keratitis. UV light has long been known for Its ability to kill different microorganisms (such as bacterial and fungal ones).Since keratitis in humans is an important cause of blindness, and antibiotic resistance is an increasing problem worldwide, CXL proves to be an extremely valuable possibility to manage the condition with a satisfactory outcome. CXL treatments are inexpensive, easy to perform, and easy for the patient.
Wave length | 365 nm |
Illumination intensity | 3 – 9 –18 – 30 mW/cm2 |
Working distance | 50 mm ± 5mm |
Light emission | Continuous, interval or pulsed wave |
Aperture | 3–12 mm|Electronically adjusted |
Timer | Automatic timeadjustment: 30 – 10 – 5 – 3 min |
Electric power | 100–240V|50/60 Hz |
Dimensions hard case | 37 x 46 x 15cm |
Total weight | 7kg |
- 3 - 30 mW
- Continuous, pulsed and LASIK radiation mode
- EyeTracker
- Integrated Pachymeter optiona
- Colour touch screen
- Comprehensive treatment reports (pdf)
- Bluetooth interface